Upper Limb and Nail Bed Anatomy

Wednesday, October 5, 2016 / 7:00-8:00 pm Central Time

Improved surgical confidence in the use of Mohs surgery to treat SCC, BCC and invasive tumors of the upper extremity may be influenced by improved understanding of key regional areas that present challenging anatomy. This webinar is designed to provide participants with a view of the anatomy of the upper extremity through a combination of micro-dissected un-embalmed cadaveric material, anatomic description of superficial regions relevant to dermatologic surgery and overview of points of vulnerability for traversing neurovascular structures.

Purchase the recording

  • ACMS Members, Associate Applicants, Fellows-in-training: $75
  • Non-members: $250

PARTICIPANTS: Access the recording and claim your CME certificate

Learning Objectives
At the end of this activity, the learner will be able to:

  1. Recall the architectural arrangement of the proximal nail fold, nail matrix, nail bed and hyponychium;
  2. Describe the superficial anatomy of the arm, forearm and hand with a focus on points of vulnerability of superficially traversing neurovascular structures;
  3. Review the cutaneous innervation of the upper extremity;
  4. Identify anatomical regions within which structures (eg. brachial plexus) may be susceptible to injury during invasive tumor resection: - supraclavicular triangle, axillary floor;
  5. Explain the anatomical relations of the superficial bursae and their connection with the joint cavities.

CME: 1.00 Credit Hour

Presenter
Nirusha Lachman, PhD, is a professor in the Department of Anatomy, College of Medicine with joint appointment in the Department of Surgery, Division of Plastic Surgery at Mayo Clinic. Her primary focus lies in integrating anatomy education for everyday practice, and she is one of few clinical anatomists in the world who works collaboratively on a daily basis with clinicians in a practice-based setting. In her 20-year career as a clinical anatomist, Dr. Lachman has contributed at least 57 scientific publications in peer reviewed journals, 16 book chapters and numerous abstract publications and national and international presentations.

Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the American College of Mohs Surgery (ACMS). The ACMS is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement
The ACMS designates this internet live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
To comply with the ACCME Standards of Commercial Support on the need for disclosure and monitoring of proprietary and financial interests that may affect the scientific integrity and balance of content delivered in continuing medical education activities under our auspices. The ACMS requires that all CME certified activities be developed free from the control of a commercial interest and be balanced, objective, and scientifically rigorous. Anyone with the ability to affect the content of an educational activity must disclose relevant financial relationships with health organizations producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Disclosure of Discussion of Non-FDA Approved Uses for Pharmaceutical Products and/or Medical Devices
The ACMS requires that all faculty presenters identify and disclose any off-label uses for pharmaceutical and medical device products. The ACMS recommends that each physician fully review all the available data on new products or procedures prior to instituting them with patients.

Interest Disclosures
As an organization accredited by the ACCME to sponsor continuing medical education activities, the ACMS is required to disclose any real or apparent conflicts of interest (COI) that any speakers may have related to the content of their presentations. The ACMS requires that all individuals (including spouse/domestic partner) in a position to control/influence content in a program designated for AMA Physician’s Recognition Award Category 1 credits™ disclose any financial interest/arrangement or affiliation with an ACCME-defined commercial organization that may impact on his/her presentation (i.e. grants, research support, honoraria, member of speakers’ bureau, consultant, major stock shareholder, etc.). In addition, the faculty member must disclose when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during the educational activity.

No Interests to Disclose:
Nirusha Lachman, PhD
Jeremy S. Bordeaux, MD, MPH FACMS*
Jerry D. Brewer, MD, FACMS*
Mariah R. Brown, MD, FACMS*
Matthew C. Fox, MD, FACMS*
Sailesh Konda, MD*
Ravi Krishnan, MD, FACMS*
Rajiv I. Nijhawan, MD, FACMS*
Mark A. Russell, MD, FACMS*
Fiona M. Zwald, MD, MRCPI, FACMS*

Relevant Conflicts of Interest to Disclose**:
John G. Albertini, MD, FACMS*                                  Research/Grant Support - Genentech

*Indicates CME & Education Committee Members
**Having a financial relationship with an ACCME-defined commercial organization, or discussing an unlabeled use of a commercial product, may not prevent a faculty member from participating in the planning process. However, the existence of a relevant financial relationship must be disclosed, so that any relevant conflict of interest may be resolved prior to that individual’s participation in the CME activity.

Disclaimer
The views expressed and the techniques presented by the speaker of the ACMS-sponsored educational activity are not necessarily shared or endorsed by the organizations. Anyone with the ability to affect the content of an educational activity must disclose relevant financial relationships with health organizations producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, as well as any unapproved or off-label uses of medical devices or pharmaceutical agents that they discuss, describe, or demonstrate during their presentations. Participants should use their independent judgment in applying the information discussed in this webinar in the treatment of patients.